Can primary recurrences in surgical stage I-II uterine papillary serous carcinoma (UPSC) patients be salvaged?

被引：0
|
作者：
Fader, A. Nickles [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Rose, P. G. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Frasure, H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Gehrig, P. A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Moore, K. N. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Havrilesky, L. J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Huh, W. K. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Axtell, A. E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
O'Malley, D. M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Zanotti, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[5] Duke Univ, Med Ctr, Durham, NC USA
[6] Univ Alabama, Birmingham, AL USA
[7] Univ Calif Los Angeles, Olive View, Los Angeles, CA USA
[8] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16503
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy
    Kelly, MG
    O'Malley, DM
    Hui, P
    McAlpine, J
    Yu, H
    Rutherford, TJ
    Azodi, M
    Schwartz, PE
    GYNECOLOGIC ONCOLOGY, 2005, 98 (03) : 353 - 359
  • [2] Outcomes in surgical stage I uterine papillary serous carcinoma
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    Bae-Jump, Victoria
    Ayeni, Tina
    Calingaert, Brian
    Clarke-Pearson, Daniel L.
    Berchuck, Andrew
    Gehrig, Paola A.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 677 - 682
  • [3] The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC)
    Dietrich, CS
    Modesitt, SC
    DePriest, PD
    Ueland, FR
    Wilder, J
    Reedy, MB
    Pavlik, EJ
    Kryscio, R
    Cibull, M
    Giesler, J
    Manahan, K
    Huh, W
    Cohn, D
    Powell, M
    Slomovitz, B
    Higgins, R
    Merritt, W
    Hunter, J
    Puls, L
    Gehrig, P
    van Nagell, JR
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 557 - 563
  • [4] An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
    Fader, Amanda Nickles
    Starks, David
    Gehrig, Paola A.
    Secord, Angeles Alvarez
    Frasure, Heidi E.
    O'Malley, David M.
    Tuller, Erin R.
    Rose, Peter G.
    Havrilesky, Laura J.
    Moore, Kathleen N.
    Huh, Warner K.
    Axtell, Allison E.
    Kelley, Joseph L.
    Zanotti, Kristine M.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (02) : 244 - 248
  • [5] Patterns of Relapse in Stage I-II Uterine Papillary Serous Carcinoma Treated With Adjuvant Intravaginal Radiation (IVRT)
    Desai, N. B.
    Kiess, A. P.
    Kollmeier, M. A.
    Abu-Rustum, N. R.
    Makker, V.
    Barakat, R.
    Alektiar, K. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S423 - S424
  • [6] A phase I study of imatinib mesylate and paclitaxel in patients with advanced (stage IIIC/IV) or recurrent uterine papillary serous carcinoma (UPSC)
    Slomovitz, B. M.
    Ramondetta, L. M.
    Johnston, T.
    Lu, K. H.
    Broaddus, R. R.
    Muller, P.
    Iyer, R. B.
    Burke, T. W.
    Gershenson, D. M.
    Wolf, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] 7 Gy x 2-An Effective Brachytherapy Regimen for Stage I-II Uterine Papillary Serous Carcinoma
    Damast, S.
    Higgins, S. A.
    Ratner, E.
    de Leon, M. C. B.
    Mani, S.
    Silasi, D.
    Azodi, M.
    Santin, A.
    Rutherford, T.
    Schwartz, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S420 - S421
  • [8] Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy
    Huh, WK
    Powell, M
    Leath, CA
    Straughn, JM
    Cohn, DE
    Gold, MA
    Falkner, CA
    Carey, DE
    Herzog, T
    Fowler, JM
    Partridge, EE
    Kilgore, LC
    Alvarez, RD
    GYNECOLOGIC ONCOLOGY, 2003, 91 (03) : 470 - 475
  • [9] Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy
    Desai, Neil B.
    Kiess, Ana P.
    Kollmeier, Marisa A.
    Abu-Rustum, Nadeem R.
    Makker, Vicky
    Barakat, Richard R.
    Alektiar, Kaled M.
    GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 604 - 608
  • [10] Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?
    Amit, Amnon
    Sabo, Edmond
    Movsas, Avielle
    Efrat-Tamam, Yamit
    Reiss, Ari
    Matanes, Emad
    Klorin, Geula
    PLOS ONE, 2019, 14 (02):
12345